India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

New Delhi — Chinese and Japanese injection molding machinery makers are planning capacity expansions in India to meet growth in the country's domestic market, particularly with higher-tonnage machines ...

The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

DUBLIN--(BUSINESS WIRE)--The "India Large Volume Parenteral (LVP) Market Analysis Report By Volume, By Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), By End Use ...

Husky Injection Molding Systems (Bolton, ON), manufacturer of hot runners, PET perform molds, and injection molding machinery, has broken ground on a new facility in Chennai, India. Planned there are ...

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

ROSTI has chosen Chennai as the ideal location of the new plant as majority of its customers are concentrated in and around the area. The ROSTI facility in Chennai aims to serve the India market and ...

Rosti Group is expanding in India ahead of schedule, signing an extension for its new injection molding facility in Chennai before the original plant is even complete. The 80,000-square-foot expansion ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.